CPX-351 from MyBioSource.com

Supplier Page

Supplier Page from
MyBioSource.com for
CPX-351

Get Pricing

Description

CPX-351 is a Liposomal-encapsulated combination of daunorubicin and cytarabine for the treatment of newly identified tAML or AML with myelodysplasia-related changes (AML-MRCs)